in Australia most of our population is unvaccinated
we have 3 vaccines approved by our government
Pfizer (extremely limited supply), Astra Zeneca (abundant stock, 6 Australian clot deaths), Moderna (supply due to arrive later this year)
people under 40 are excluded from the official government vaccine rollout
they are turned away if they show up and refused a booking if they call to book
(except for priority groups, yesterday pregnant woment were included in the priority Pfizer rollout group)
people eligible for the Pfizer vaccine are having difficulty accessing the vaccine, there is not enough stock
recently the official reports showed one mass vaccination hub in VIC ... vaccinated 50 people
in NSW, where the Delta variant in in the community, second doses of Pfizer are being postponed or cancelled, to allow more first doses to be given
the Moderna vaccine is not being offered to anyone
i talked to a teacher here who is desperate to get vaccinated, they deal with the public and children every day at their work
they are young and not included in the official government priority list (for their designated vaccine, Pfizer)
the only choice they have is to risk taking the Astra Zeneca vaccine, by seeking it out privately and signing a waiver for their doctor
some people are understandably nervous about the Astra Zeneca vaccine
(5 people here have died of thrombocytopenia syndrome (TTS) and 1 of immune thrombocytopenia (ITP))
the reality for most of our population?
Astra Zeneca, or nothing
we have ... Hobsons' choice
The media has down played it a lot, but the vaccine isn't effective against the variant out of India.
incorrect
reduced efficacy is not the same as inefficacy
According to figures gathered by Public Health Scotland and
published in the Lancet, at least two weeks after the second dose of Covid jabs, protection against infection fell from 92% for the Alpha variant to 79% against the Delta variant for the Pfizer/BioNTech vaccine, while for the Oxford/AstraZeneca vaccine the protection fell from 73% to 60% respectively.
Protection against symptomatic disease has also been found to differ depending on the variant.
According to the
latest figures from Public Health England (PHE), four weeks after one dose, either vaccine offered almost 50% protection against the Alpha variant. However for the Delta variant this protection was lower, with one dose of the Pfizer/BioNTech jab offering about 36% protection against symptomatic disease. For one dose of the Oxford/AstraZeneca vaccine this figure was about 30%.
Two weeks after the second dose, the differences in vaccine effectiveness by variant were more modest, with the Pfizer/BioNTech jab offering 88% protection against symptomatic disease with the Delta variant, compared with 94% protection against the Alpha variant. For the Oxford/AstraZeneca vaccine, the figures were 67% and 74% respectively.
*
www.theguardian.com/world/2021/jun/15/the-covid-delta-variant-how-effective-are-the-vaccines